Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. GlavMed
WARNING LETTER
•GlavMed•September 19, 2017

GlavMed – FDA Warning Letter, Sep 19, 2017

Record Details

On September 19, 2017, the FDA issued a Warning Letter to GlavMed, citing violations of the Federal Food, Drug, and Cosmetic Act (FD&C Act) for offering unapproved new drugs and misbranded drugs for sale to U.S. consumers via multiple websites.

The FDA determined that products sold on GlavMed's websites are unapproved new drugs under sections 201(g) and 201(p) of the FD&C Act, as they are intended for disease treatment or to affect body structure/function and are not generally recognized as safe and effective. Examples include oral chloramphenicol, which has no approved applications and was previously withdrawn from the U.S. market due to serious safety concerns (e.g., fatal blood disorders, aplastic anemia) and the availability of safer alternatives. Roxithromycin, also offered, has never had FDA approval in the U.S. The introduction of these unapproved drugs into interstate commerce violates sections 301(d) and 505(a) of the FD&C Act.

Furthermore, GlavMed's websites offer prescription drugs, such as chloramphenicol and roxithromycin, without requiring a prescription, which misbrands them under section 503(b)(1) of the FD&C Act. Dispensing prescription drugs without a valid prescription violates section 301(k).

Company
GlavMed
Inspection date
September 19, 2017
Product type
Drugs
Office
Center for Drug Evaluation and Research
Person
  • Thomas (TJ) Christl (Office Director)
View Company Profile

ID · 095e073f-f656-4844-b828-499d4aeac698

Violation Codes10
21 U.S.C. 353(b)(1)21 U.S.C. 321(g)21 U.S.C. 331(d)21 U.S.C. 331(k)21 U.S.C. 353(b)21.U.S.C. 355(a)21 U.S.C. 321(p)21 U.S.C. 352(f)(1)21 CFR 201.521 U.S.C. 331(a)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore GlavMed
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.